The SCDM Annual Conference 2016 was held this year in Hyderabad, India. India being a pivotal point in a rapidly growing eco system, the conference has been built around the idea of providing a platform for professionals to converge and share their knowledge and expertise in the field.The theme for the year's conference was aptly identified as "CDM in Digital Health DM 2.0: Technology|Data|Analytics".
This is the third conference to be hosted by SCDM in India. The conference focused in the data management and sciences space which gives greater content depth and is reflective of the speakers and panelists who have a great deal of hands-on experience. The program had topics that covered current practices as well as emerging models like analytics, data science and risk based monitoring.
Demetris Zambas(Head, Data Science, Novartis), Dr. Vijay Chauthaiwale (Political Activist and Independent Healthcare-Biotech Consultant), Dr. Nimita Limaye (CEO, Nymro Clinical Consulting Services), Dr. Appalla Venkataprabhakar (India Head- Clinical Database and Global Library Oncology Data Sciences, Novartis), Shannon Labout (VP, Education, CDISC) and Mayank Anand (Director, DOTS, Biometrics, INC Research) and Artem Andrianov (CEO, Cyntegrity) inaugurated the conference by showcasing the footprint and success of SCDM India and its future vision.
The first day started with workshop on Project Management by Abhishek Ghosh, Director-CDM, QuintilesIMS followed by keynote session-"Technology Disruption Leading to Data Challenges" by Dr. Vijay Chauthaiwale (In Charge, Foreign Affairs Dept, BJP and HC-Biotech Consultant). He shared his research work connecting with real life examples on how Technology disruption can be a question mark to data. He also touched on how technology (wearables/AI/Drones) will have fundamental impact on how we do things and also mentioned the different type of risks that the technology can create.
Parallel sessions were conducted in two days. Artem Andrianov (CEO, Cyntegrity) chaired the session on "Implementing Risk Based Monitoring" where various professionals presented and shared their expertise, and built a perspective on the importance of RBM, implementation of RBM in oncology trials and on how to streamline operational outcomes for Centralizing Monitoring.